Optogenetics and mRNA Vaccines Net Lasker Awards
Optogenetics and mRNA Vaccines Net Lasker Awards
This year’s winners are Dieter Oesterhelt, Peter Hegemann, Karl Deisseroth, Drew Weissman, Katalin Karikó, and David Baltimore.
Optogenetics and mRNA Vaccines Net Lasker Awards
Optogenetics and mRNA Vaccines Net Lasker Awards

This year’s winners are Dieter Oesterhelt, Peter Hegemann, Karl Deisseroth, Drew Weissman, Katalin Karikó, and David Baltimore.

This year’s winners are Dieter Oesterhelt, Peter Hegemann, Karl Deisseroth, Drew Weissman, Katalin Karikó, and David Baltimore.

vaccines
Moderna vs. Pfizer: Is There a “Best” mRNA Vaccine?
Moderna vs. Pfizer: Is There a “Best” mRNA Vaccine?
Alejandra Manjarrez | Sep 24, 2021
Both of the mRNA vaccines available in the US are highly effective against severe COVID-19, but recent studies suggest that Moderna’s elicits a stronger immune response and might be better at preventing breakthrough infections.  
Book Excerpt from <em>You Bet Your Life</em>
Book Excerpt from You Bet Your Life
Paul A. Offit | Sep 21, 2021
In his book’s Introduction, physician-scientist Paul A. Offit reviews the unusual constellation of circumstances around the development of COVID-19 vaccines.
Immunologist Thomas Hodge Dies of COVID-19 at 69
Immunologist Thomas Hodge Dies of COVID-19 at 69
Lisa Winter | Aug 30, 2021
A former academic and consultant, Hodge cofounded the CrisiScience Collective to help combat the pandemic.
Updated
Wealthier Nations Disregarding WHO Call for COVID-19 Booster Moratorium
Wealthier Nations Disregarding WHO Call for COVID-19 Booster Moratorium
Christie Wilcox | Aug 5, 2021
The organization implored nations to wait on booster shots until the global vaccination rate increases, but several of the world’s more well-off countries have expressed their intentions to offer them regardless.
Infographic: TB Vaccines in the Pipeline Take Varied Approaches
Infographic: TB Vaccines in the Pipeline Take Varied Approaches
Anthony King | Jul 1, 2021
More than a dozen vaccines for tuberculosis are currently being tested in clinical trials. Some use whole bacteria as BCG does, while others deliver protein subunits or genetic material carried by viral vectors.  
Tuberculosis: The Forgotten Pandemic
Tuberculosis: The Forgotten Pandemic
Anthony King | Jul 1, 2021
This month marks the 100-year anniversary of BCG, still the only approved vaccine against the lethal pathogen. But there are new vaccines for this wily foe on the horizon.
Mucosal Vaccines Protect Mice from Viruses, Cancer
Mucosal Vaccines Protect Mice from Viruses, Cancer
Emma Yasinski | Jun 1, 2021
Scientists use a protein found in mucus membranes to ferry vaccines to the lymph nodes.
Biden Administration Backs Vaccine Intellectual Property Waiver
Biden Administration Backs Vaccine Intellectual Property Waiver
Amanda Heidt | May 10, 2021
The move, which is not supported by the pharmaceutical industry, would allow other countries to design and manufacture COVID-19 vaccines without fear of litigation.
COVID-19 mRNA Vaccines Appear Effective Against Multiple Variants
COVID-19 mRNA Vaccines Appear Effective Against Multiple Variants
Lisa Winter | May 6, 2021
Data from three studies indicate that fully vaccinated patients are able to stave off severe disease from the B.1.1.7, B.1.351, and P.1 variants.
No Proof COVID-19 Vaccine Affects Menstruation or Fertility
No Proof COVID-19 Vaccine Affects Menstruation or Fertility
Lisa Winter | Apr 27, 2021
Following vaccination, some women claim their periods have changed, leading to rumors about how the shots affect recipients’ reproductive systems, and even others’ by proxy.  
Scientists Reverse Engineer mRNA Sequence of Moderna Vaccine
Scientists Reverse Engineer mRNA Sequence of Moderna Vaccine
Lisa Winter | Apr 6, 2021
Stanford University researchers determined the code from spare drops in discarded vials of the COVID-19 vaccine and published it on GitHub.
Pfizer&rsquo;s COVID-19 Vaccine Reduces Viral Load: Study
Pfizer’s COVID-19 Vaccine Reduces Viral Load: Study
Asher Jones | Feb 10, 2021
Preliminary results from an Israel-based study suggest that one dose of the vaccine reduces infectiousness—a key factor in slowing virus spread.
New SARS-CoV-2 Variant Could Evade Antibodies
New SARS-CoV-2 Variant Could Evade Antibodies
Lisa Winter | Jan 22, 2021
A preprint casts doubt on vaccine effectiveness in light of certain mutations in the 501Y.V2 variant that emerged from South Africa.